SCHEMBL7439680

SCHEMBL7439680

CCOC(=O)Nc1ccc(C(C)N)c(C)c1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A1 P00352 3/20 0.44
NLRP3 Q96P20 3/20 0.42
HPGD P15428 3/20 0.41
NPSR1 Q6W5P4 1/20 0.39
KCNQ3 O43525 3/20 0.39
KCNQ2 O43526 3/20 0.39
METAP2 P50579 1/20 0.39
NPC1 O15118 1/20 0.38
CRHBP P24387 1/20 0.38
RAB9A P51151 1/20 0.38
CRHR2 Q13324 1/20 0.38
PTPN1 P18031 1/20 0.38
MAPK1 P28482 2/20 0.37
HSD17B10 Q99714 2/20 0.37
KCNQ4 P56696 1/20 0.37
KCNQ5 Q9NR82 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7441131 0.88 CYP1A2 (0.47) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL27474471 0.78 CYP1A2 (0.53) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL27474459 0.78 ALDH1A1 (0.62) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL9029629 0.76 CYP1A2 (0.48) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL10489823 0.76 NLRP3 (0.60) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL27248569 0.74 SMN1; SMN2 (0.54) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL30076159 0.72 ALDH1A1 (0.51) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL27248817 0.72 CYP1A2 (0.49) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL27248809 0.72 ALDH1A1 (0.51) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL27248819 0.72 SMN1; SMN2 (0.48) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0741715-B1 NOVEL HUMAN LEUKOCYTE ELASTASE (HLE) INHIBITORS, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE STANFORD RES INST INT (US) 1998-08-26 EP disclosed
WO-1995020581-A1 NOVEL HUMAN LEUKOCYTE ELASTASE (HLE) INHIBITORS, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE SRI INTERNATIONAL (US) 1995-08-03 WO disclosed
US-5428021-A Administering to inhibit serine proteases SRI INTERNATIONAL (US) 1995-06-27 US disclosed